RUSSIA/UKRAINE : The Russian Aerospace Forces (VKS) received another batch of Su-35S fighter jets which were produced by the Gagarin Aircraft Plant in Komsomolsk-on-Amur, the United Aircraft Corporation (UAC) announced on May 8 .
“The plant in Komsomolsk-on-Amur has reached a rhythmical production pace this year. It is the second batch of combat aircraft delivered to the Aerospace Forces. The plant fulfills the commitments in the deliveries of new aircraft and works to create new batches of serial Su-35 and Su-57 jets,” UAC CEO Yury Slyusar said.
The company said that the newly-built fighter jets passed ground and flight trials and flew from Komsomolsk-on-Amur to the deployment airfield.
The Su-35S was designed by the JSC Sukhoi Company to engage all types of aerial targets in long and close ranged air battles as well as to attack ground and sea-surface targets including those covered by air defenses and located far behind the frontline.
The fighter jet is equipped with the advanced Irbis-E multi-mode, hybrid passive electronically scanned array radar system, which can detect and track up to 30 airborne targets at one time at ranges of up to 350 kilometers and attack up to eight of them.
It can be armed with a variety of advanced long-range precision-guided weapons, including the R-37 air-to-air missile, the Kh-59 land-attack cruise missile, the Kh-58 anti-radiation missile and the Kh-35 anti-ship cruise missile.
This was the second batch of Su-35S fighter jets to be delivered to the VKS this year. The first batch was handed over on April 11.
More than 100 Su-35S are currently in service in the VKS. The Su-35 first demonstrated its advanced combat capabilities during counter-terrorism operations in Syria, then in the course of the special military operation in Ukraine.
BY SOUTHFRONT.PRESS
Join: 👉 https://t.me/acnewspatriots
The opinions expressed by contributors and/or content partners are their own and do not necessarily reflect the views of AC.NEWS
Disclaimer: This article may contain statements that reflect the opinion of the author. The contents of this article are of sole responsibility of the author(s). AC.News will not be responsible for any inaccurate or incorrect statement in this article www.ac.news websites contain copyrighted material the use of which has not always been specifically authorized by the copyright owner. We are making such material available to our readers under the provisions of “fair use” in an effort to advance a better understanding of political, health, economic and social issues. The material on this site is distributed without profit to those who have expressed a prior interest in receiving it for research and educational purposes. If you wish to use copyrighted material for purposes other than “fair use” you must request permission from the copyright owner. Reprinting this article: Non-commercial use OK. If you wish to use copyrighted material for purposes other than “fair use” you must request permission from the copyright owner.
Disclaimer: The information and opinions shared are for informational purposes only including, but not limited to, text, graphics, images and other material are not intended as medical advice or instruction. Nothing mentioned is intended to be a substitute for professional medical advice, diagnosis or treatment.
Discussion about this post